X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Patent (206) 206
Journal Article (62) 62
Publication (9) 9
Book Chapter (1) 1
Book Review (1) 1
Streaming Video (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (206) 206
hygiene (206) 206
medical or veterinary science (206) 206
preparations for medical, dental, or toilet purposes (206) 206
microbiology (201) 201
chemistry (198) 198
metallurgy (198) 198
beer (194) 194
biochemistry (194) 194
enzymology (194) 194
mutation or genetic engineering (194) 194
spirits (194) 194
vinegar (194) 194
wine (194) 194
compositions thereof (190) 190
culture media (190) 190
microorganisms or enzymes (190) 190
propagating, preserving or maintaining microorganisms (190) 190
general tagging of cross-sectional technologies spanning over several sections of the ipc (171) 171
general tagging of new technological developments (171) 171
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (171) 171
technologies for adaptation to climate change (170) 170
technologies or applications for mitigation or adaptation againstclimate change (170) 170
organic chemistry (153) 153
peptides (145) 145
specific therapeutic activity of chemical compounds ormedicinal preparations (95) 95
compositions or test papers therefor (48) 48
condition-responsive control in microbiological orenzymological processes (48) 48
measuring or testing processes involving enzymes, nucleicacids or microorganisms (48) 48
processes of preparing such compositions (48) 48
derivatives thereof (36) 36
nucleic acids (36) 36
nucleosides (36) 36
nucleotides (36) 36
sugars (36) 36
animals (34) 34
humans (23) 23
immunology (19) 19
mice (18) 18
viruses (18) 18
vaccines (17) 17
female (15) 15
japanese encephalitis (15) 15
virus replication (13) 13
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (12) 12
nonhuman-primates (12) 12
vero cells (12) 12
virology (12) 12
vaccine (11) 11
viral vaccines - immunology (11) 11
yellow fever virus - genetics (11) 11
cercopithecus aethiops (10) 10
immunization (10) 10
immunogenicity (10) 10
index medicus (10) 10
medicine, research & experimental (10) 10
flavivirus (9) 9
flavivirus - immunology (9) 9
proteins (9) 9
dengue virus - genetics (8) 8
infection (8) 8
infectious diseases (8) 8
live (8) 8
recombinant (8) 8
vaccines, attenuated - immunology (8) 8
yellow-fever virus (8) 8
amino acid sequence (7) 7
antibodies, viral - blood (7) 7
dengue virus - immunology (7) 7
encephalitis virus, japanese - genetics (7) 7
male (7) 7
safety (7) 7
vaccination (7) 7
viral envelope proteins - immunology (7) 7
virulence (7) 7
antigens, viral - immunology (6) 6
biotechnology & applied microbiology (6) 6
cell line (6) 6
dengue - prevention & control (6) 6
encephalitis (6) 6
encephalitis virus, japanese - immunology (6) 6
infections (6) 6
japanese encephalitis vaccines - immunology (6) 6
kinetics (6) 6
mice, inbred icr (6) 6
molecular sequence data (6) 6
public, environmental & occupational health (6) 6
tropical medicine (6) 6
vaccines, synthetic - immunology (6) 6
veterinary sciences (6) 6
west-nile-virus (6) 6
aedes - virology (5) 5
allergy and immunology (5) 5
attenuated vaccine (5) 5
chimera (5) 5
dengue (5) 5
enzyme-linked immunosorbent assay (5) 5
genetic vectors (5) 5
hydrogen-ion concentration (5) 5
neutralization tests (5) 5
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (247) 247
French (75) 75
German (33) 33
Chinese (10) 10
Portuguese (10) 10
Norwegian (5) 5
Spanish (4) 4
Czech (3) 3
Danish (2) 2
Hungarian (2) 2
Korean (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2015, Vaccines : principles, recent developments and future directions
Web Resource
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 4/2006, Volume 103, Issue 17, pp. 6694 - 6699
West Nile (WN) virus is an important cause of febrile exanthem and encephalitis. Since it invaded the U.S. in 1999, >19,000 human cases have been reported. The... 
T lymphocytes | Inoculation | Viremia | Vaccination | Placebos | Clinical trials | Viruses | Dosage | Vero cells | Yellow fever | Clinical trial | Non-human primate | clinical trial | yellow fever | IN-VIVO SYNTHESIS | SAFETY | MULTIDISCIPLINARY SCIENCES | INTERFERON GAMMA-PRODUCTION | CHIMERIVAX-JE | LANGERHANS CELLS | IMMUNIZATION | non-human primate | T-CELL RESPONSES | ENCEPHALITIS | YELLOW-FEVER VIRUS | INFECTION | Viral Vaccines - pharmacology | Humans | Vaccines, Synthetic - pharmacology | Viral Vaccines - genetics | Macaca fascicularis | Molecular Sequence Data | Male | Neutralization Tests | West Nile Fever - prevention & control | Vaccines, Attenuated - pharmacokinetics | West Nile virus - genetics | Adult | Female | Safety | Vaccines, Synthetic - toxicity | Vaccines, Attenuated - pharmacology | West Nile Fever - virology | West Nile virus - physiology | Double-Blind Method | West Nile Fever - immunology | West Nile virus - immunology | Vaccines, Synthetic - genetics | Viral Vaccines - pharmacokinetics | Animals | Vaccines, Attenuated - toxicity | Virus Replication | Adolescent | T-Lymphocytes - immunology | Viral Vaccines - toxicity | Vaccines, Attenuated - genetics | Yellow fever virus - genetics | Prevention | West Nile fever | Physiological aspects | Care and treatment | Vaccines | Research | Biological Sciences
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2018, Volume 77, p. 57
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 10/2003, Volume 188, Issue 8, pp. 1213 - 1230
ChimeriVax-JE is a live, attenuated vaccine against Japanese encephalitis, using yellow fever (YF) 17D vaccine as a vector. In a double-blind phase 2 trial, 99... 
HIV/AIDS | Inoculation | Viremia | Neutralizing antibodies | Vaccination | Antibodies | Placebos | Viruses | Dosage | Yellow fever | Japanese encephalitis | DENGUE | INFECTIOUS DISEASES | EFFICACY | RECOMBINANT | YELLOW-FEVER VACCINE | STRAIN 17D | ANTIBODY-RESPONSE | FLAVIVIRUS INFECTION | MONKEYS | ARTHROPOD-BORNE VIRUSES | ENVELOPE GENES | Yellow Fever Vaccine - administration & dosage | Encephalitis, Japanese - virology | Humans | Vaccines, Inactivated | Viral Vaccines - genetics | Neutralization Tests | Viral Vaccines - adverse effects | Antibodies, Viral - blood | Dose-Response Relationship, Drug | Vaccines, Attenuated - administration & dosage | Immunization Schedule | Japanese Encephalitis Vaccines - administration & dosage | Yellow Fever Vaccine - adverse effects | Double-Blind Method | Yellow Fever Vaccine - immunology | Japanese Encephalitis Vaccines - immunology | West Nile Virus Vaccines | Treatment Outcome | Japanese Encephalitis Vaccines - adverse effects | Encephalitis Virus, Japanese - genetics | Viral Vaccines - administration & dosage | Antigens, Viral - immunology | Vaccines, Attenuated - immunology | Yellow Fever Vaccine - genetics | Animals | Encephalitis, Japanese - prevention & control | Immunologic Memory | Mice | Genetic Vectors | Vaccines, Attenuated - adverse effects | Viral Vaccines - immunology | Encephalitis Virus, Japanese - immunology | Yellow fever virus - genetics | Evaluation | Care and treatment | Clinical trials | Adverse and side effects | Research | Vaccines | Patients | Prevention | Analysis | Causes of | Physiological aspects | Airborne infection | Dosage and administration | Health aspects
Journal Article
American Journal of Tropical Medicine and Hygiene, ISSN 0002-9637, 2017, Volume 97, Issue 5, pp. 1410 - 1417
Journal Article
Journal Article
Pathogens (Basel, Switzerland), ISSN 2076-0817, 08/2019, Volume 8, Issue 3, p. 133
Lassa fever surpasses Ebola, Marburg, and all other hemorrhagic fevers except Dengue in its public health impact. Caused by Lassa virus (LASV), the disease is... 
replication-deficient MVA vector | VLP formation | Lassa vaccine | single-dose efficacy | cell-mediated immunity
Journal Article
Journal of Virology, ISSN 0022-538X, 02/2002, Volume 76, Issue 4, pp. 1932 - 1943
Journal Article